Hypera S.A.

BOVESPA:HYPE3 Stok Raporu

Piyasa değeri: R$14.8b

Hypera Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

Hypera şirketinin kazançları yıllık ortalama -6.5% oranında azalırken, Pharmaceuticals sektörünün kazançları yıllık 8.6% oranında artan oldu. Gelirler yıllık ortalama 7% oranında artan oldu. Hypera şirketinin öz sermaye getirisi 11.9% olup, net marjı 19.5% dir.

Anahtar bilgiler

-6.48%

Kazanç büyüme oranı

-6.50%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi12.39%
Gelir büyüme oranı7.04%
Özkaynak getirisi11.86%
Net Marj19.45%
Sonraki Kazanç Güncellemesi06 Aug 2026

Yakın geçmiş performans güncellemeleri

Analiz Makalesi May 07

Hypera's (BVMF:HYPE3) Solid Profits Have Weak Fundamentals

Hypera S.A.'s ( BVMF:HYPE3 ) robust earnings report didn't manage to move the market for its stock. We did some...
Analiz Makalesi Nov 05

Hypera's (BVMF:HYPE3) Anemic Earnings Might Be Worse Than You Think

Hypera S.A.'s ( BVMF:HYPE3 ) stock showed strength, with investors undeterred by its weak earnings report. We think...

Recent updates

Analiz Makalesi May 07

Hypera's (BVMF:HYPE3) Solid Profits Have Weak Fundamentals

Hypera S.A.'s ( BVMF:HYPE3 ) robust earnings report didn't manage to move the market for its stock. We did some...
Anlatı Güncellemesi Feb 05

HYPE3: Index Exit And Higher Margin Outlook Will Support Future Upside

Analysts have slightly reduced their price target on Hypera to reflect updated assumptions on fair value, revenue growth, profit margin and future P/E, while keeping the overall outlook broadly consistent with prior estimates. What's in the News Hypera S.A. removed from the Brazil IBRX 50 Index, which may affect how index-linked funds and some institutional investors are exposed to the stock (Key Developments).
Anlatı Güncellemesi Jan 20

HYPE3: Slight Index Exit And Firm P/E Outlook Will Support Upside

Analysts have nudged their price target for Hypera slightly lower to reflect small adjustments in fair value, discount rate, revenue growth, profit margin and future P/E assumptions, resulting in a modest trim of about R$0.15 per share. What's in the News Hypera S.A. removed from the Brazil IBRX 50 Index, which may affect how some index and benchmark aware investors treat the stock (Key Developments).
Anlatı Güncellemesi Jan 05

HYPE3: Future P/E Multiple Expansion Will Support Further Upside Potential

Analysts have slightly increased their price target on Hypera to reflect updated fair value estimates and adjustments to revenue growth, profit margin expectations, and future P/E assumptions. What's in the News Hypera S.A. is scheduled to hold a board meeting on Dec 11, 2025, which may address governance, capital allocation, or operational planning (company event filing).
Analiz Makalesi Dec 28

Hypera (BVMF:HYPE3) Takes On Some Risk With Its Use Of Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Anlatı Güncellemesi Dec 15

HYPE3: Future P E Expansion Will Support Further Upside Potential

Analysts have slightly raised their price target on Hypera to $30.24 from $30.14, citing modestly stronger revenue growth expectations that more than offset a small downward revision in projected profit margins and a higher implied future P/E multiple. Valuation Changes Fair Value Estimate has risen slightly from R$30.14 to R$30.24 per share, reflecting a modestly higher intrinsic valuation.
Analiz Makalesi Dec 01

What You Can Learn From Hypera S.A.'s (BVMF:HYPE3) P/E

When close to half the companies in Brazil have price-to-earnings ratios (or "P/E's") below 9x, you may consider Hypera...
Anlatı Güncellemesi Dec 01

HYPE3: Future P/E Expansion Signals Continued Upside Potential

Analysts have increased their price target for Hypera from $29.59 to $30.14, citing revised estimates that reflect a slightly higher discount rate as well as updated projections for revenue growth and profit margin. Valuation Changes Fair Value: Increased slightly from R$29.59 to R$30.14 per share.
Analiz Makalesi Nov 05

Hypera's (BVMF:HYPE3) Anemic Earnings Might Be Worse Than You Think

Hypera S.A.'s ( BVMF:HYPE3 ) stock showed strength, with investors undeterred by its weak earnings report. We think...
Analiz Makalesi Sep 05

Does Hypera (BVMF:HYPE3) Have A Healthy Balance Sheet?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analiz Makalesi Aug 10

Hypera S.A. Just Beat EPS By 8.0%: Here's What Analysts Think Will Happen Next

It's been a sad week for Hypera S.A. ( BVMF:HYPE3 ), who've watched their investment drop 10% to R$23.19 in the week...
Analiz Makalesi Jun 15

The Price Is Right For Hypera S.A. (BVMF:HYPE3)

With a price-to-earnings (or "P/E") ratio of 21.7x Hypera S.A. ( BVMF:HYPE3 ) may be sending very bearish signals at...
Analiz Makalesi Apr 23

Does Hypera (BVMF:HYPE3) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analiz Makalesi Mar 27

Hypera's (BVMF:HYPE3) Weak Earnings May Only Reveal A Part Of The Whole Picture

Hypera S.A.'s ( BVMF:HYPE3 ) recent weak earnings report didn't cause a big stock movement. However, we believe that...
User avatar
Yeni Anlatı Mar 23

Product Expansion And Investments In Chronic Treatments Will Strengthen Future Operations

Hypera's working capital focus will improve cash flow, enhancing net margins and financial stability through inventory and operational efficiency enhancements.
Analiz Makalesi Feb 24

Why Investors Shouldn't Be Surprised By Hypera S.A.'s (BVMF:HYPE3) P/E

With a median price-to-earnings (or "P/E") ratio of close to 8x in Brazil, you could be forgiven for feeling...
Analiz Makalesi Nov 21

More Unpleasant Surprises Could Be In Store For Hypera S.A.'s (BVMF:HYPE3) Shares After Tumbling 27%

To the annoyance of some shareholders, Hypera S.A. ( BVMF:HYPE3 ) shares are down a considerable 27% in the last month...
Analiz Makalesi Nov 14

We Think Hypera (BVMF:HYPE3) Is Taking Some Risk With Its Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analiz Makalesi Oct 03

Investors Appear Satisfied With Hypera S.A.'s (BVMF:HYPE3) Prospects

There wouldn't be many who think Hypera S.A.'s ( BVMF:HYPE3 ) price-to-earnings (or "P/E") ratio of 10x is worth a...
Analiz Makalesi Jul 13

We Think Hypera (BVMF:HYPE3) Is Taking Some Risk With Its Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analiz Makalesi Jun 20

Hypera S.A.'s (BVMF:HYPE3) Popularity With Investors Is Under Threat From Overpricing

It's not a stretch to say that Hypera S.A.'s ( BVMF:HYPE3 ) price-to-earnings (or "P/E") ratio of 10.9x right now seems...
Analiz Makalesi Mar 16

Hypera S.A. (BVMF:HYPE3) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Investors in Hypera S.A. ( BVMF:HYPE3 ) had a good week, as its shares rose 3.3% to close at R$34.10 following the...
Analiz Makalesi Feb 21

Is Hypera (BVMF:HYPE3) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analiz Makalesi Jan 09

Here's Why Hypera (BVMF:HYPE3) Has Caught The Eye Of Investors

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Analiz Makalesi Dec 22

Hypera S.A.'s (BVMF:HYPE3) Business Is Yet to Catch Up With Its Share Price

It's not a stretch to say that Hypera S.A.'s ( BVMF:HYPE3 ) price-to-earnings (or "P/E") ratio of 12.7x right now seems...
Analiz Makalesi Nov 02

Hypera (BVMF:HYPE3) Has A Somewhat Strained Balance Sheet

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analiz Makalesi Aug 27

Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Analiz Makalesi Jul 21

Is Hypera (BVMF:HYPE3) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analiz Makalesi Apr 15

We Think Hypera (BVMF:HYPE3) Is Taking Some Risk With Its Debt

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analiz Makalesi Feb 19

With EPS Growth And More, Hypera (BVMF:HYPE3) Makes An Interesting Case

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analiz Makalesi Jan 03

We Think Hypera (BVMF:HYPE3) Can Stay On Top Of Its Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analiz Makalesi Oct 11

Is Now The Time To Put Hypera (BVMF:HYPE3) On Your Watchlist?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analiz Makalesi Jul 31

Hypera S.A. (BVMF:HYPE3) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

It's been a good week for Hypera S.A. ( BVMF:HYPE3 ) shareholders, because the company has just released its latest...
Analiz Makalesi Jul 19

Is Hypera (BVMF:HYPE3) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analiz Makalesi Jun 28

Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Analiz Makalesi Apr 14

Here's Why Hypera (BVMF:HYPE3) Can Manage Its Debt Responsibly

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Analiz Makalesi Mar 25

I Ran A Stock Scan For Earnings Growth And Hypera (BVMF:HYPE3) Passed With Ease

Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
Analiz Makalesi Mar 04

Subdued Growth No Barrier To Hypera S.A.'s (BVMF:HYPE3) Price

Hypera S.A.'s ( BVMF:HYPE3 ) price-to-earnings (or "P/E") ratio of 13x might make it look like a sell right now...

Gelir ve Gider Dağılımı

Hypera nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

BOVESPA:HYPE3 Gelir, gider ve kazançlar (BRL Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
31 Mar 268,6361,6802,7830
31 Dec 257,6991,1962,7950
30 Sep 256,9738252,7930
30 Jun 256,6627462,8000
31 Mar 256,6978112,8210
31 Dec 247,4421,3432,6540
30 Sep 247,7781,5702,5480
30 Jun 248,0011,6932,5070
31 Mar 248,0431,7042,5110
31 Dec 237,9151,6492,5210
30 Sep 238,1891,7722,5310
30 Jun 238,0861,7412,4920
31 Mar 237,7511,6942,3750
31 Dec 227,5461,7052,2990
30 Sep 227,0511,6402,1210
30 Jun 226,6481,6362,0170
31 Mar 226,2601,6601,9550
31 Dec 215,9371,6181,8950
30 Sep 215,4461,5771,8720
30 Jun 214,9021,4621,7560
31 Mar 214,4451,3821,6260
31 Dec 204,0891,3221,5640
30 Sep 203,8831,2431,5380
30 Jun 203,8031,1651,6050
31 Mar 203,7261,1061,6350
31 Dec 193,2951,1891,6110
30 Sep 193,2941,2521,5580
30 Jun 193,2331,2251,5080
31 Mar 193,1801,1641,4690
31 Dec 183,7241,1351,4810
30 Sep 183,7891,2881,5080
30 Jun 183,7161,2511,4770
31 Mar 183,6131,2001,4300
31 Dec 173,5001,1111,4100
30 Sep 173,2918191,3970
30 Jun 173,2267951,3800
31 Mar 173,2167431,3940
31 Dec 163,2286471,3720
30 Sep 163,2025571,3600
30 Jun 163,1294321,3390
31 Mar 163,0463491,3230
31 Dec 152,9573451,3070
30 Sep 151,5892637740
30 Jun 152,0393269440

Kaliteli Kazançlar: HYPE3 yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: HYPE3 'nin mevcut net kar marjları (19.5%) geçen yılın (12.1%) sinden daha yüksektir.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: HYPE3 şirketinin kazançları son 5 yılda yılda 6.5% oranında azaldı.

Büyüme Hızlandırma: HYPE3 'un son bir yıldaki kazanç büyümesi ( 107.2% ) 5 yıllık ortalamasını (yıllık -6.5% ) aşıyor.

Kazançlar vs. Sektör: HYPE3 geçen yılki kazanç büyümesi ( 107.2% ) Pharmaceuticals sektörünün 10.3% değerini aştı.


Özkaynak Getirisi

Yüksek ROE: HYPE3 'nin Özsermaye Getirisi ( 11.9% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/06/10 21:42
Gün Sonu Hisse Fiyatı2026/06/09 00:00
Kazançlar2026/03/31
Yıllık Kazançlar2025/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Hypera S.A. 21 Bu analistlerden 12, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Andréa AznarBB Banco de Investimento S.A.
Robert Ford AguilarBofA Global Research
Marcio OsakoBradesco S.A. Corretora de Títulos e Valores Mobiliários